DSCI Key Stats
- Derma Sciences' CEO Hosts Analyst Day Conference (Transcript) Seeking Alpha Jun 13
- Sanuwave: DermaPACE Could Be Very Competitive In $2B Diabetic Foot Ulcer Market Jun 12
- Published Research Concludes Total Contact Casting is More Effective in Healing ... Jun 12
- Derma Sciences reports positive results from Phase 1 diabetic foot ulcer study Jun 12
- Derma Sciences (DSCI) Says No PK Parameters Could Be Calculated in Latest Study Street Insider Jun 12
- Derma Sciences Reports Results from DSC127 Pharmacokinetic Study Business Wire Jun 12
- Derma Sciences to Webcast June 12 Analyst Day Business Wire Jun 7
- Did Derma Sciences Squander Its Latest Sales Increase? Fool Jun 7
- Derma Sciences Appoints Medical Device Veteran Amy S. Paul to Its Board of Direc... May 24
- DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Office... May 24
DSCI Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Derma Sciences is up 46.74% over the last year vs S&P 500 Total Return up 25.82%, AngioDynamics down 8.96%, and KMA up 0.00%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for DSCI
Pro Report PDF for DSCI
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download DSCI Pro Report PDF
Pro Strategies Featuring DSCI
Did Derma Sciences make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.